SCHEMBL8795332

SCHEMBL8795332

CCNc1cc2ncnc(NCc3cccc(OCCO)c3)c2cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
PDGFRB P09619 1/20 0.46
EGFR P00533 6/20 0.45
MAPK1 P28482 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
AURKA O14965 4/20 0.44
RPS6KB1 P23443 4/20 0.44
AURKB Q96GD4 1/20 0.44
CLK4 Q9HAZ1 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796500 0.90 MEN1 (0.46) HTTPDGFRBEGFRMAPK1MEN1
SCHEMBL8825746 0.89 HTT (0.62) HTTEGFRMAPK1SMN1; SMN2AURKA
SCHEMBL8796312 0.89 AURKA (0.49) HTTPDGFRBEGFRMAPK1SMN1; SMN2
SCHEMBL8795923 0.89 HTT (0.46) HTTPDGFRBEGFRMAPK1SMN1; SMN2
SCHEMBL8795456 0.88 HTT (0.46) HTTPDGFRBEGFRMAPK1SMN1; SMN2
SCHEMBL8795595 0.87 EGFR (0.49) HTTPDGFRBEGFRMAPK1CLK4
SCHEMBL8796055 0.86 RPS6KB1 (0.47) HTTPDGFRBEGFRMAPK1SMN1; SMN2
SCHEMBL8796103 0.85 AURKA (0.56) HTTPDGFRBEGFRMAPK1SMN1; SMN2
SCHEMBL8796911 0.84 AURKA (0.52) PDGFRBEGFRAURKARPS6KB1AURKB
SCHEMBL8825839 0.84 EGFR (0.62) HTTEGFRMAPK1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698560-A TREATMENT OF CARDIOVASCULAR DISORDERS; ANTICOAGULANTS; CARDIOTONIC AGENTS; HYPOTENSIVE AGENTS; ARTERIOSCLEROSIS; CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-12-16 US disclosed
EP-0758653-A1 IMIDAZOQUINAZOLINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-02-19 EP disclosed